Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: China Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20121
20134
20153
20173
20184
20194
20203
20218
20231
20242
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Active, not recruiting10
Completed9
Unknown status9
Terminated3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Jiangsu HengRui Medicine Co., Ltd.4
Beihua Kong2
Fudan University2
Genmab2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Suzhou Suncadia Biopharmaceuticals Co., Ltd.2
Tongji Hospital2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms47
Fallopian Tube Neoplasms14
Carcinoma, Ovarian Epithelial6
Neoplasms3
Peritoneal Neoplasms3
Recurrence3
Endometrial Neoplasms2
Uterine Cervical Neoplasms2
Breast Neoplasms1
Carcinoma1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.